posted June 02, 2022 07:51 am by AviseAnalytics
(4)
Harmony Biosciences, Inc. (NASDAQ: HRMY) is a commercial-stage biopharmaceutical company developing novel therapeutics for rare and orphan diseases, focusing on central nervous system disorders.
...read more